Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Cole Stang"'
Autor:
Pierpaolo Turcano, Jessie Jacobson, Khaled Ghoniem, Aidan Mullan, Emanuele Camerucci, Cole Stang, Capucine Piat, James H. Bower, Rodolfo Savica
Publikováno v:
Frontiers in Neurology, Vol 15 (2024)
IntroductionImpulse control disorders (ICDs) are defined as excessive and repetitive behaviors that may affect Parkinson’s disease (PD) patients exposed to dopamine agonists. Current data on ICDs in patients with early-onset Parkinson’s disease (
Externí odkaz:
https://doaj.org/article/ac76df6a37754f13919b41b02d26babb
Autor:
Fabrice Lucien, Eduardo E Benarroch, Aidan Mullan, Farwa Ali, Bradley F Boeve, Michelle M Mielke, Ronald C Petersen, Yohan Kim, Cole Stang, Emanuele Camerucci, Owen A Ross, Zbigniew K Wszolek, David Knopman, James Bower, Wolfgang Singer, Rodolfo Savica
Publikováno v:
PLoS ONE, Vol 17, Iss 4, p e0264446 (2022)
Background/objectiveDespite multiple attempts, no surrogate biomarker of Parkinson disease (PD) has been definitively identified. Alternatively, identifying a non-invasive biomarker is crucial to understanding the natural history, severity, and progr
Externí odkaz:
https://doaj.org/article/d81d16b4bf1845a1a9d4cd0d5e3350bd
Autor:
Jessie Jacobson, Khaled Ghoniem, Aidan Mullan, Pierpaolo Turcano, Emanuele Camerucci, Cole Stang, James Bower, Rodolfo Savica
Publikováno v:
Monday, April 24.
Autor:
Stuart McCarter, Emanuele Camerucci, Aidan Mullan, Cole Stang, Pierpaolo Turcano, Erik St. Louis, Bradley Boeve, James Bower, Rodolfo Savica
Publikováno v:
Tuesday, April 25.
Autor:
Khaled Ghoniem, Jessie Jacobson, Aidan Mullan, Pierpaolo Turcano, Emanuele Camerucci, Cole Stang, James Bower, Rodolfo Savica
Publikováno v:
Monday, April 24.
Autor:
Fabrice Lucien, Eduardo E. Benarroch, Aidan Mullan, Farwa Ali, Bradley F. Boeve, Michelle M. Mielke, Ronald C. Petersen, Yohan Kim, Cole Stang, Emanuele Camerucci, Owen A. Ross, Zbigniew K. Wszolek, David Knopman, James Bower, Wolfgang Singer, Rodolfo Savica
Publikováno v:
PloS one. 17(4)
Background/Objective Despite multiple attempts, no surrogate biomarker of Parkinson disease (PD) has been definitively identified. Alternatively, identifying a non-invasive biomarker is crucial to understanding the natural history, severity, and prog